Allied Academies

Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academies Conferences

Advances in Neuroscience Research and Clinical Practice

Welcome Message

On behalf of the organizing committee, it is my great pleasure to extend a warm welcome to all of you for the 8th International Conference on Neurological Disorders and Stroke, taking place from March 14th to 16th, 2019, in the vibrant city of London, UK.

Under the theme of "Innovations in Diagnostics, Treatments, and Rehabilitation of Neurological Diseases and Stroke," this conference serves as a remarkable platform for the convergence of leading experts, researchers, practitioners, and industry professionals from around the world. Together, we aim to foster a dynamic exchange of knowledge, ideas, and insights, shaping the future of neurological medicine.

The field of neuroscience has witnessed unprecedented progress in recent years, and this conference stands as a testament to the remarkable breakthroughs and advancements made in understanding, diagnosing, and treating neurological disorders and stroke. Throughout the three days of this event, we will explore cutting-edge research, groundbreaking technologies, and novel therapeutic approaches that are reshaping the landscape of neurological care.

London, with its rich history, cultural diversity, and world-class medical institutions, provides an ideal backdrop for this intellectually stimulating gathering. Beyond the scientific program, we encourage you to immerse yourself in the city's unique charm and beauty, fostering new friendships and collaborations that will last beyond the conference.

We extend our heartfelt gratitude to all the speakers, sponsors, and participants who have contributed to the success of this conference. Your presence and active engagement ensure that we collectively strive towards a healthier, more informed, and compassionate world, where the burden of neurological diseases and stroke is alleviated.

We hope that this conference proves to be a transformative experience for each one of you. May it be a catalyst for inspiration, innovation, and a deeper commitment to advancing the frontiers of neurological research and care.

See you in London!

Warm regards,

Organizing Committee 

Stroke 2019

Market Analysis

Market Size and Demographics: Start by gathering data on the prevalence of neurological disorders in London and the UK as a whole. Look for statistics on the number of patients diagnosed with various neurological conditions, such as Alzheimer's, Parkinson's, epilepsy, multiple sclerosis, etc. Also, consider the age distribution and other relevant demographics of the affected population.

Competitor Analysis: Identify existing healthcare providers, research institutions, and companies that are already working on neurological disorders in London. Analyze their services, treatments, and market share. This will help you understand the competitive landscape and potential barriers to entry.

Regulatory Environment: Understand the regulatory framework governing neurological disorder treatments and therapies in the UK. Ensure that your products or services comply with the necessary regulations and approvals from health authorities.

Trends and Innovations: Stay up-to-date with the latest trends and advancements in the field of neurology. This could include new treatment methods, diagnostic technologies, or research breakthroughs that might impact the market.

Patient Needs and Preferences: Conduct surveys or gather data on patient preferences, unmet needs, and pain points related to neurological disorders. Understanding the patient's perspective can help tailor your offerings to better address their concerns.

Key Stakeholders: Identify key stakeholders in the neurology market, such as healthcare providers, hospitals, neurologists, insurers, and patient advocacy groups. Understanding their interests and roles will help you form strategic partnerships.

Market Potential and Growth Opportunities: Based on the data you've collected, assess the overall market potential for neurological disorder treatments and services in London. Project future growth opportunities and potential demand.

Market Entry Strategy: Develop a comprehensive market entry strategy considering your findings from the analysis. This strategy should outline your value proposition, target customer segments, pricing, distribution channels, and marketing plan.

Financial Projections: Estimate the financial viability of your business or services. Include projected revenues, expenses, and profit margins. Consider the upfront investment required for research, development, and marketing.

Risks and Mitigation: Identify potential risks and challenges in entering the market. These could include regulatory hurdles, competition, economic factors, or technological challenges. Develop mitigation strategies for each identified risk.

Scientific Sessions/Tracks

  • Neurological Disorders
  • Stroke
  • Neurology
  • Ischemic Stroke
  • Dementia
  • Epilepsy
  • Psychiatry
  • Amyloidosis
  • Animal Models Testing
  • Neuroscience
  • Guillain Barre Syndrome
  • Parkinson’s Diseases
  • Alzheimer's Disease
  • Neuroimaging And Neuro-sonology
  • Neurodegenerative Disorders
  • Cerebrovascular Disease
  • Neonatal And Pediatric Stroke
  • Cognitive Impairment
  • Demyelinating Disease
  • Movement Disorders
  • Pediatric Neurology
  • Neuroscience
  • Neuro therapy

Session on Neurological Disorders

Diseases of the central and peripheral nervous systems are considered neurological disorders. These conditions include neurological problems as a result of malnutrition, epilepsy, Alzheimer's disease, and other dementias, cerebrovascular diseases such as stroke, migraine, and other headache disorders, multiple sclerosis, Parkinson's disease, neuro infections, and brain tumors.

Session on Stroke

In recent days, so many people have been affected by Stroke, including infants. The stroke management market is divided into hospitals, diagnostic centres, outpatient surgical centres, and others. In 2021, the hospital sector has a market share of nearly 42 percent. Too many individuals lose their lives to strokes. How to prevent stroke, types of strokes, and other disorders can be elaborated through Stroke 2023. The types of strokes are Brain stroke, pediatric stroke, Neonatal stroke, and Ischemic stroke.

Session on Neurology

In 2020, the size of the worldwide neuroscience market was $36.5 billion. Looking ahead, IMARC Group projects that the market will increase at a compound annual growth rate (CAGR) of 4.1% from 2022 to 2028, reaching $46.2 billion by 2031. Neurology is a rapidly evolving field, with ongoing research and development of new treatments and therapies. Advances in neuroscience and technology have led to an improved understanding of the brain and nervous system and opened up new avenues for the diagnosis and treatment of neurological disorders.

Session on Dementia

Dementia is a type of Neurological Disorder, It is a set of symptoms that substantially affect memory, thinking, and social abilities and are referred to as dementia when they significantly interfere with day-to-day functioning. Numerous conditions can cause dementia, even if there isn't one specific sickness that does.

Session on Epilepsy

Epilepsy is one of the Neurological disorders that cause seizures or periods of unusual behavior, abnormal brain activity sensations, and sometimes loss of awareness. Both men and women in all ethnic groups are affected by epilepsy. According to data from the World Health Organization, the average cost of healthcare per person globally in 2018 was USD 1,154.731. The cost of healthcare per person globally went from USD 784.313 in 2010 to USD 1,320.841 in 2019, with the United States as the top payer at USD 11,643.85 per capita in 2019.

Session on Psychiatry

In the field of medicine known as psychiatry, mental, emotional, and behavioral problems are identified, treated, and prevented. A psychiatrist is a medical specialist who focuses on mental health, notably substance use disorders.

Session on Amyloidosis

The market for treatments for transthyretin amyloidosis was valued at USD 4.822 billion in 2020 and is projected to grow to USD 7.11 billion by 2025. The size of the worldwide market for amyloidosis treatments was estimated at USD 3.7 billion in 2018 and is projected to grow at a CAGR of 6.9% during the forecast period. Some of the reasons that will jointly drive the market are the expanding elderly population, the increased acceptance of innovative targeted treatments and transplantation, the introduction of biologics, and these.


Session on Animal Models Testing

In recent years Animal models Testingwas a trending topic in Neurology. The market for animal models was valued at USD 17.27 billion in 2019 and is anticipated to rise to USD 29.08 billion by 2025, at a CAGR of 10.29%. Neuroscience, pharmacology, toxicology, and genetics are just a few of the scientific areas that employ animal models. Animals including mice, rats, rabbits, dogs, and non-human primates are frequently utilized as models which will be briefly elaborated at Stroke Conference.

Session on NeuroScience

Modern Neuroscience has several branches, such as affective neuroscience, behavioral neuroscience, cellular neuroscience, clinical neuroscience, cognitive neuroscience, cultural neuroscience, molecular neuroscience, and social neuroscience.

Session on Guillain-Barre Syndrome

Peripheral nervous system disease called Guillain-Barre syndrome. During the projection period, 2021-2026, the Guillain-Barre Syndrome Market Study is expected to expand at a CAGR of 4.9%. The COVID-19 virus has a substantial effect on the market for Guillain-Barre syndrome (GBS) treatments.

Session on Parkinson’s Diseases

Tremors, stiffness, bradykinesia (slow movement), and postural instability are all signs of Parkinson's disease. Other symptoms may include a loss of smell, sleep disturbances, constipation, depression, and cognitive impairment. The market for medications for Parkinson's disease was estimated to be worth $5.9 billion globally in 2020; it is anticipated to increase to $11.2 billion by 2028, with a CAGR of 6.8% from 2020 to 2035. Parkinson's disease is a neurodegenerative condition commonly known as idiopathic Parkinsonism.

Session on Alzheimer's Disease

Alzheimer's disease is a neurodegenerative disorder that affects the brain, causing a decline in cognitive function and memory loss. In older people, it is the most typical cause of dementia. The Global market rate for Alzheimer’s disease was estimated to be worth $4.3 billion in 2019 and $6.2 billion by 2023, with a CAGR of 6.3% during the period of 2019-2023.

Session on Neuroimaging and Neurosonology

Neuroimaging and neurosonology are both diagnostic tools used in the field of neurology to help visualize and study the structure and function of the brain and nervous system. Neuroimaging refers to a group of techniques used to create images of the brain and its structures. Neurosonolgy is one of the diagnostic tools that use ultrasound technology.

Session on Neurodegenerative Disorders

The market for neurodegenerative diseases was estimated to be worth USD 39,125 million in 2020, and it is anticipated to grow to USD 78,295 million by 2035, showing a CAGR of 6.2% during the projected period (2020–2035).

Session on Cerebrovascular Disease

Treatment for Cerebrovascular disease depends on the underlying condition and the severity of the symptoms. Medications may be used to help prevent blood clots and reduce the risk of stroke or TIA, and surgery or endovascular procedures may be necessary to repair damaged blood vessels or prevent further damage. Cerebrovascular disease knowledge was very important these are briefly elaborated on the Stroke 2023.

Session on Neonatal and Pediatric Stroke

For neonatal and pediatric stroke, respectively, the average adjusted 5-year expenditures are significant at $54,719 and $135,168. The average price of admission for a youngster with a stroke was $91,869. Neonatal stroke birth admission expenses were on average $49,633; when these prices were adjusted for control birth admission costs, the difference was just $5,792, indicating that the stroke was responsible for 87% of the expenditures.

Session on Cognitive Impairment

Depending on the underlying reason, treatment for cognitive impairment may involve drugs to control symptoms, cognitive and behavioral therapy, lifestyle changes, and supportive care. Early detection and treatment of cognitive impairment are crucial because certain causes of it may be reversible if discovered and addressed quickly enough. The cognitive impairment will be explained in Stroke 2023.

Session on Demyelinating Disease

The protective coating known as the myelin sheath, which covers nerve fibers in the central and peripheral nervous systems, is a structure that is harmed by a set of illnesses known as demyelinating diseases. Numerous symptoms, including muscular weakness, tingling or numbness in the limbs, issues with balance and coordination, as well as issues with vision and speech, can be brought on by these illnesses.

Session on Movement Disorders

This market research study on the treatment of dementia and movement disorders offers insightful information on the market's response to COVID-19, which will assist businesses in assessing their strategic business plans. The researcher at Technavio projects that the market for treating dementia and mobility disorders would be worth USD 8.14 billion by 2030, growing at a CAGR of 7.95%.

Session on Pediatric Neurology

A specialty of medicine called pediatric neurology is dedicated to identifying and treating neurological disorders in infants and children. Pediatric neurologists are medical professionals with specialized training in this area who are prepared to treat newborns, kids, and teenagers with neurological issues.

Session on Neurotherapy

Neurotherapy, also known as neurofeedback or EEG biofeedback, is a type of therapy that uses real-time feedback from the brain to help individuals learn to regulate and control their brainwave activity. The market for Neurotherapy is anticipated to reach $ 1,236.6 million in 2021 and grow at a CAGR of 7.4% from 2021 to 2027.

Renowned Speakers

To Collaborate Scientific Professionals around the World

Conference Date March 14-16, 2019
Poster Oppurtunity Available
e-Poster Oppurtunity Available
Copyright © 2024 Allied Academies, All Rights Reserved.